Atara Biotherapeutics, Inc. (ATRA)
NASDAQ: ATRA · Real-Time Price · USD
9.48
+0.25 (2.71%)
Oct 9, 2026, 4:00 PM EDT - Market closed
Atara Biotherapeutics Market Cap
Atara Biotherapeutics has a market cap or net worth of $95.16 million as of October 9, 2026. It is the 25,786th most valuable company in the world and the 4,156th biggest in the United States. Its market cap has decreased by 14.50% in one year.
Market Cap
95.16M
Enterprise Value
95.16M
1-Year Change
-14.50%
Global Rank
Country Rank
#4,156 United States
Category
ChartMarket Cap Chart
Since October 16, 2014, Atara Biotherapeutics's market cap has decreased from $215.30M to $95.16M, a decrease of -55.80%. That is a compound annual growth rate of -6.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 95.20M | -26.99% |
| Dec 31, 2025 | 130.40M | 70.01% |
| Dec 31, 2024 | 76.70M | 46.65% |
| Dec 29, 2023 | 52.30M | -83.19% |
| Dec 30, 2022 | 311.20M | -77.67% |
| Dec 31, 2021 | 1.39B | -8.65% |
| Dec 31, 2020 | 1.53B | 71.04% |
| Dec 31, 2019 | 891.90M | -43.76% |
| Dec 31, 2018 | 1.59B | 186.35% |
| Dec 29, 2017 | 553.80M | 35.14% |
| Dec 30, 2016 | 409.80M | -45.80% |
| Dec 31, 2015 | 756.10M | 39.84% |
| Dec 31, 2014 | 540.70M | 151.14% |
| Oct 16, 2014 | 215.30M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| PolyPid | 102.07M |
| Aardvark Therapeutics | 101.87M |
| Anixa Biosciences | 101.86M |
| Polaryx Therapeutics | 101.19M |
| OnKure Therapeutics | 95.57M |
| Cellectis | 92.40M |
| Neumora Therapeutics | 92.07M |
| Equillium | 91.31M |